More Information »Malignant Brain Tumor (MBT) domains are a family of methylated lysine-recognizing transcriptional repressors. They possess a methyl-lysine (Kme) binding pocket along with other Kme reader proteins, but MBT domains selectively recognize mono- and dimethylated lysines.
MBT Domain Products
Product Name / Activity
|Potent inhibitor of L3MBTL3 Kme reader domain; cell permeable|
|4516||UNC 926 hydrochloride|
|L3MBTL1 domain inhibitor|